Real-world data on safety and efficacy of venetoclax-based regimens in relapsed/refractory t(11;14) multiple myeloma.

Br J Haematol · 2020 · PMC9291136 · PMID 32012228

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a positive trendno p-value reported

This same study, however, showed a positive trend in OS in patients with t(11;14) treated with venetoclax (Kumar et al. , 2019 ) .

also in 11,005 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.